National Institute of Pharmaceutical Education and Research, Raebareli has entered into a strategic collaboration with Lofty Laboratories through the signing of a Memorandum of Understanding (MoU), Confidential...
Intra-Cellular Therapies, Inc. announced the presentation of a new network meta-analysis (NMA) demonstrating that CAPLYTA® (lumateperone) showed the greatest improvement across four key efficacy outcomes among...